Skip to main content
  • Italian
  • English
Home Multichem R&D
  • Italian
  • English

Navigazione principale

  • About us
  • Products
    • Nicomenthyl 20
    • Nicomenthyl Hot
    • Nicomenthyl Cool
    • Nicomenthyl Fresh
  • FAQ
    • FAQ Nicomenthyl 20
  • Science
    • Patents
    • Multichem publications
    • Scientific references
    • Blog
  • News center
  • Contacts
    • Distributors
    • How can we help you?

Nicotinamide riboside

Viral infection as an NAD+ battlefield

Charles Brenner
Published on 03 January 2022
Topics:
NAD
NAM
Nicotinamide
NR
Nicotinamide riboside
  • Read more about Viral infection as an NAD+ battlefield

NAD+ in COVID-19 and viral infections

Minyan Zheng, Michael B. Schultz, and David A. Sinclair
Published on February 10, 2022
Topics:
COVID-19
NAD
NMN [nicotinamide monocleotide]
NR
Nicotinamide riboside
Niacin
Nicotinic Acid
  • Read more about NAD+ in COVID-19 and viral infections

Understanding the immune response in COVID-19 – new opportunities and new insights

Professor Guy Richards - Charlotte Maxeke Academic Hospital, Johannesburg
Published on July 2021
Topics:
COVID-19
NAD
Nicotinamide
Nicotinamide riboside
Nicotinic Acid
  • Read more about Understanding the immune response in COVID-19 – new opportunities and new insights

Subscribe to our newsletter

To stay informed about new developments of our researches.

logo-multichem-300.png

MULTICHEM R&D s.r.l. | Via Guglielmo Marconi 37 - 20089 Rozzano - (MI) Italy - Phone +39 02 8262192‬ - Mail: info@multichem.it - VAT: IT03541880237

Footer menu

  • Contacts
  • Careers
  • Cookies
  • Privacy
  • Preferences
  • Company data